Schonfeld Strategic Advisors LLC Fulgent Genetics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$19.09 - $22.57 $268,596 - $317,559	14,070 Added 79.81%	31,700 $621,000
Q1 2024 May 15, 2024	BUY	$21.55 - $29.29 $194,596 - $264,488	9,030 Added 105.0%	17,630 $382,000
Q4 2023 Feb 14, 2024	SELL	$23.64 - $30.27 $309,684 - $396,537	-13,100 Reduced 60.37%	8,600 $248,000
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $206,700 - $315,461	7,730 Added 55.33%	21,700 $580,000
Q2 2023 Aug 14, 2023	BUY	$28.52 - $40.7 $398,424 - $568,579	13,970 New	13,970 $517,000
Q4 2022 Feb 14, 2023	SELL	$29.23 - $40.28 $47,644 - $65,656	-1,630 Reduced 10.48%	13,923 $414,000
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $86,723 - $145,773	2,287 Added 17.24%	15,553 $593,000
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $636,502 - $832,441	13,266 New	13,266 $724,000
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $127,566 - $245,945	-2,559 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $197,810 - $268,695	2,559 New	2,559 $257,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.